logo
Helios Technologies Launches Atlas Connect Gateway, a Rugged and Smart Connectivity Solution for Intelligent Equipment

Helios Technologies Launches Atlas Connect Gateway, a Rugged and Smart Connectivity Solution for Intelligent Equipment

Business Wire3 days ago
SARASOTA, Fla.--(BUSINESS WIRE)-- Helios Technologies, Inc. (NYSE: HLIO) ('Helios' or the 'Company'), a global leader in highly engineered motion control and electronic controls technology, is excited to announce the launch of the Atlas Connect Gateway, an advanced connectivity solution developed by Enovation Controls, part of Helios' Electronics segment. Engineered to meet the rigorous demands of modern applications across a wide range of industries, this new offering delivers the next generation of secure connectivity, remote diagnostics, and real-time system intelligence. With seamless integration into Helios' broader ecosystem, Atlas Connect Gateway is purpose-built to support original equipment manufacturers (OEM) that require both performance and serviceability, allowing them to connect different devices and systems which ordinarily may not be compatible.
'The launch of the Atlas Connect Gateway marks a major step forward in Helios Technologies' vision for intelligent machine connectivity,' commented Sean Bagan, President, Chief Executive Officer and Chief Financial Officer of Helios. 'We're proud to deliver this rugged, future-ready solution to customers around the world, helping them stay connected, informed, and in control. This is another strong demonstration of our teams' ability to introduce innovative products that deliver significant value to customers in diverse end markets.'
The Atlas Connect Gateway gives equipment manufacturers and operators greater insight and control by allowing them to monitor critical data, send remote commands, and update software on equipment in the field without needing to be on site. Its powerful processing capabilities enable fast, reliable performance even in the field, making it easier to keep machines running smoothly and efficiently.
'By pairing the Atlas Connect Gateway with Cygnus Reach, Helios' patented remote troubleshooting platform—we're delivering a powerful new advantage to OEMs by enabling remote support capabilities,' said Billy Aldridge, Senior Vice President, Managing Director – Electronics Segment. 'For organizations operating customer support centers or field service teams, this integrated solution streamlines diagnostics, reduces downtime, and elevates the overall service experience. It's a major step forward in connecting people, machines, and data in smarter, more efficient ways.'
Atlas Connect Gateway can be wired into any CAN enabled system in a matter of minutes. Using Cygnus Reach you can monitor the CAN bus, take CAN recordings, and effortlessly share data, all using your cellular mobile device. Built to thrive in demanding field conditions, the Atlas Connect Gateway is IP67-rated and engineered for durability in extreme environments. It operates reliably in temperatures ranging from -4°F to 158°F (-20°C to 70°C) and can be safely stored between -13°F and 167°F (-25°C to 75°C). Its wide operating voltage of 6–36 VDC makes it suitable for use across many types of equipment.
This innovative solution will be available in August 2025, with feature demonstrations scheduled in the Enovation Controls' booth at both The Utility Expo and IBEX later this year. These premier industry events will give attendees an opportunity to experience its capabilities up close and explore how it enables smarter equipment in even the toughest environments.
About Enovation Controls
Enovation Controls is a fast-growing and innovative manufacturer of electronic controls and displays for diverse markets. As an international leader in fully tailored solutions, Enovation Controls offers a broad range of displays, controls, and instrumentation products for various applications. With an internationally diverse team, we serve customers around the world through our global sales, manufacturing, and engineering operations. Enovation Controls partners directly with OEMs and supports a worldwide network of authorized distributors and system integrators. Visit us at www.enovationcontrols.com and follow us on LinkedIn.
About Helios Technologies
Helios Technologies is a global leader in highly engineered motion control and electronic controls technology for diverse end markets, including construction, material handling, agriculture, energy, recreational vehicles, marine and health and wellness. Helios sells its products to customers in over 90 countries around the world. Its strategy for growth is to be the leading provider in niche markets, with premier products and solutions through innovative product development and acquisition. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information, please visit: www.heliostechnologies.com and follow us on LinkedIn.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Roblox (RBLX) Shares Are Soaring Today
Why Roblox (RBLX) Shares Are Soaring Today

Yahoo

time28 minutes ago

  • Yahoo

Why Roblox (RBLX) Shares Are Soaring Today

July 31 - Roblox Corp. (NYSE:RBLX) shares climbed 15% Thursday morning after delivering a blockbuster second-quarter report, fueled by a surprise hit game and surging user engagement. Warning! GuruFocus has detected 6 Warning Signs with RBLX. The stock also jumped 19% before the opening bell, extending its 205% gain over the past year, far outpacing the Nasdaq 100's 24% rise. The gaming platform's bookings, a key metric Wall Street follows, climbed 51% year over year, smashing analyst estimates of 34% growth. Daily active users jumped 41%, and hours spent on the platform soared 58%. Much of that momentum came from Grow a Garden, a farming simulation created by user BMWLux, which reached 21 billion visits and set a record with 22 million concurrent players in June. Roblox continues to invest heavily in cloud infrastructure to handle massive traffic surges, a strategy that has begun to pay off. While the company posted a GAAP operating loss of $1.1 billion over the past 12 months, it generated $942 million in free cash flow and ended June with $4.7 billion in cash and investments. Deferred revenue swelled to $5.1 billion, giving Roblox a solid foundation to push toward long-term profitability. This article first appeared on GuruFocus.

Denise LeMay Joins Eastern Bank As Senior Vice President, Head of Foreign Exchange and Derivative Sales, Commercial Banking
Denise LeMay Joins Eastern Bank As Senior Vice President, Head of Foreign Exchange and Derivative Sales, Commercial Banking

Business Wire

time30 minutes ago

  • Business Wire

Denise LeMay Joins Eastern Bank As Senior Vice President, Head of Foreign Exchange and Derivative Sales, Commercial Banking

BOSTON--(BUSINESS WIRE)-- Eastern Bank is pleased to welcome Denise LeMay as Senior Vice President, Head of Foreign Exchange and Derivative Sales, Commercial Banking. Ms. LeMay brings over 25 years of experience advising commercial clients on interest rate risk management and structuring complex financial solutions through derivative products. 'It's a pleasure to welcome Denise LeMay to our commercial banking team,' said Greg Buscone, Executive Vice President, Chief Commercial Banking Officer of Eastern Bank. 'She fills an important role helping commercial businesses manage risk associated with currency fluctuations and interest rates, customized to their domestic and global business needs.' Most recently, Ms. LeMay served as Senior Vice President, Treasury Capital Markets Trading Manager at M&T Bank where she advised commercial clients on the use of derivative products to manage interest rate risk, collaborated with relationship managers to identify hedging opportunities, and played a key role in efforts around the London Interbank Offered Rate (LIBOR) to Secured Overnight Financing Rate (SOFR) transition. Previously, she built and led the Interest Rate Derivatives program at People's United Bank, growing it into a key revenue driver and serving as a senior member of the LIBOR Cessation Steering Committee. Her other career roles include treasury and trading work at Webster Bank, Calamos Asset Management, and NCM Capital Management Group with a focus on risk management and market education. 'I'm thrilled to join Eastern Bank's Commercial Banking team, which is known for putting clients first and a focus on personalized relationship banking, and I look forward to offering practical solutions to help customers meet their business goals,' said Denise LeMay, Senior Vice President, Head of Foreign Exchange and Derivative Sales, Commercial Banking of Eastern Bank. Eastern Bank provides a range of commercial financing offerings to help companies across many industries improve cash flow, increase efficiencies and build for the future. Commercial lending solutions include working capital/lines of credit, equipment/term loans, real estate loans, acquisition financing, asset-based lending, franchise lending and employee stock ownership plan-related financing. Additional services include foreign exchange solutions. About Eastern Bank Founded in 1818, Eastern Bank is Greater Boston's leading local bank with approximately 110 branch locations serving communities in eastern Massachusetts, southern and coastal New Hampshire, Rhode Island and Connecticut. As of June 30, 2025, Eastern had approximately $25.5 billion in assets. Eastern provides a full range of banking and wealth management solutions for consumers and businesses of all sizes including through its Cambridge Trust Wealth Management division, the largest bank-owned independent investment advisor in Massachusetts with $8.7 billion in assets under management, and takes pride in its outspoken advocacy and community support that includes more than $240 million in charitable giving since 1994. An inclusive company, Eastern is comprised of deeply committed professionals who value relationships with their customers, colleagues and communities. Join us for good at and follow Eastern on Facebook, LinkedIn, and Instagram. Eastern Bankshares, Inc. (Nasdaq: EBC) is the holding company for Eastern Bank. For investor information, visit

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 'What This Means' Segment
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 'What This Means' Segment

Business Upturn

time31 minutes ago

  • Business Upturn

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 'What This Means' Segment

By GlobeNewswire Published on July 31, 2025, 22:50 IST Access the 'What This Means' segment here LA JOLLA, CA, July 31, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) ('GRI Bio' or the 'Company'), a biotechnology company advancing an innovative pipeline of Natural Killer T ('NKT') cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that it participated in a Virtual Investor 'What This Means' segment. For the segment, Marc Hertz, PhD, President, Chief Executive Officer and Director of GRI, discussed the Company's recently announced 6-week interim biomarker data from its ongoing Phase 2a study in Idiopathic Pulmonary Fibrosis ('IPF'). The 'What This Means' segment can be accessed here. About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio's therapies are designed to target the activity of Natural Killer T ('NKT') cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. NKT cells are innate-like T cells that share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type I invariant NKT ('iNKT') cells play a critical role in propagating the injury, inflammatory response, and fibrosis observed in inflammatory and fibrotic indications. GRI Bio's lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis, a serious disease with significant unmet need. The Company is also developing a pipeline of novel type 2 diverse NKT ('dNKT') agonists for the treatment of systemic lupus erythematosus. Additionally, with a library of over 500 proprietary compounds, GRI Bio has the ability to fuel a growing pipeline. Investor Contact:JTC Team, LLCJenene Thomas(908) 824-0775 [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store